ONECX
Price
$20.48
Change
-$0.05 (-0.24%)
Updated
Sep 12 closing price
Net Assets
5.17B
RLBEX
Price
$38.53
Change
-$0.06 (-0.16%)
Updated
Sep 12 closing price
Net Assets
262.26B
Interact to see
Advertisement

ONECX vs RLBEX

Header iconONECX vs RLBEX Comparison
Open Charts ONECX vs RLBEXBanner chart's image
JPMorgan Investor Growth & Income C
Price$20.48
Change-$0.05 (-0.24%)
VolumeN/A
Net Assets5.17B
American Funds American Balanced R4
Price$38.53
Change-$0.06 (-0.16%)
VolumeN/A
Net Assets262.26B
ONECX vs RLBEX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ONECX vs. RLBEX commentary
Sep 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ONECX is a Hold and RLBEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBEX has more cash in the bank: 262B vs. ONECX (5.17B). ONECX pays higher dividends than RLBEX: ONECX (2.12) vs RLBEX (1.79). ONECX was incepted earlier than RLBEX: ONECX (28 years) vs RLBEX (23 years). ONECX (1.49) is less costly to investors than RLBEX (0.59). RLBEX is a more actively managed with annual turnover of: 44.00 vs. ONECX (8.00). RLBEX has a lower initial minimum investment than ONECX: RLBEX (250) vs ONECX (500). ONECX (10.39) and RLBEX (10.30) have marching annual gain over last year. RLBEX return over 5 years is better than : 43.12 vs. ONECX (30.42).
ONECXRLBEXONECX / RLBEX
Total Expense Ratio1.480.59251%
Annual Report Gross Expense Ratio1.490.59253%
Fund Existence28 years23 years-
Gain YTD11.18413.11385%
Front LoadN/AN/A-
Min. Initial Investment500250200%
Min. Initial Investment IRAN/AN/A-
Net Assets5.17B262B2%
Annual Yield % from dividends2.121.79119%
Returns for 1 year10.3910.30101%
Returns for 3 years30.1842.2271%
Returns for 5 years30.4243.1271%
Returns for 10 years45.2180.0356%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
QNCX1.600.02
+1.27%
Quince Therapeutics
RGLD189.320.13
+0.07%
Royal Gold
RKDA3.48N/A
N/A
Arcadia Biosciences
EVTC33.44-0.77
-2.25%
EVERTEC
REPL5.73-0.28
-4.66%
Replimune Group